KD

Kiruba Devi Subramaniam

Active Director Director DIN 11477688
DIN 11477688 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiruba Devi Subramaniam

Data last updated:

Kiruba Devi Subramaniam is a Director at Axcelpharm Private Limited (since 2026).

DIN 11477688
Primary Designation Director
First Appointment 12 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axcelpharm Private Limited U46497TS2026PTC209533
Director12 Jan 20262026Active

Board colleagues of Kiruba Devi Subramaniam

NameDINCompanyDesignation
Perichiappan Karuppiah11477689Axcelpharm Private LimitedDirector

Directorship timeline

Open interactive timeline →
Axcelpharm Private Limited
Premium access

Shareholding and investment profile for Kiruba Devi Subramaniam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiruba Devi Subramaniam

Kiruba Devi Subramaniam currently holds 1 directorship: Axcelpharm Private Limited (Director, since 12 Jan 2026).

Kiruba Devi Subramaniam was first appointed on 12 Jan 2026 as Director at Axcelpharm Private Limited.

The current boards of Kiruba Devi Subramaniam's companies include Perichiappan Karuppiah (Axcelpharm Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available